Literature DB >> 34034676

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor.

Kari Hemminki1,2, Asta Försti3,4, Akseli Hemminki5,6, Börje Ljungberg7, Otto Hemminki5,8,9.   

Abstract

BACKGROUND: The dominant risk factor for urinary bladder cancer has been cigarette smoking, but, as smoking prevalence is decreasing in many populations, other risk factors may become uncovered. Such new risk factors could be responsible for halting the declining incidence of bladder cancer. We hypothesize that snuff use by Swedish men may increase the rate for bladder cancer, as snuff contains carcinogenic nitrosamines.
METHODS: We carried out an ecological study by comparing incidence trends in lung and bladder cancers between Danish, Finnish and Swedish men in order to test if the Swedish bladder cancer rate deviates from the Danish and Finnish ones. We used the NORDCAN database for cancer data from 1960 through 2016 to test the hypothesis.
RESULTS: In the three countries, the incidence of lung cancer started to decrease after a peak incidence, and this was later followed by declining incidence in bladder cancer in Denmark from 1990 to 2016 by 14.3%, in Finland by 8.3% but not in Sweden (the decline of 1.4% was not significant). The difference in trends can be partly explained by the increasing incidence in Swedish men aged 70 or more years. Sweden differs from the two other countries by low male smoking prevalence but increasing use of snuff recorded by various surveys.
CONCLUSION: The stable bladder cancer trend for Swedish men was opposite to the declining trends in Denmark, Finland and globally. We suggest that this unusual finding may be related to the increasing use of snuff by Swedish men. Average users of snuff are exposed to at least 3 times higher levels of carcinogenic tobacco-specific nitrosamines than a smoker of one daily pack of cigarettes.

Entities:  

Keywords:  Incidence trend; Risk factors; Sex difference; Snuffing; Tobacco products

Year:  2021        PMID: 34034676     DOI: 10.1186/s12885-021-08371-w

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  28 in total

1.  Longitudinal relationships between lung cancer mortality rates, smoking, and ambient air quality: a comprehensive review and analysis.

Authors:  Frederick W Lipfert; Ronald E Wyzga
Journal:  Crit Rev Toxicol       Date:  2020-01-27       Impact factor: 5.635

2.  Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018.

Authors:  Marcus George Kwesi Cumberbatch; Ibrahim Jubber; Peter C Black; Francesco Esperto; Jonine D Figueroa; Ashish M Kamat; Lambertus Kiemeney; Yair Lotan; Karl Pang; Debra T Silverman; Ariana Znaor; James W F Catto
Journal:  Eur Urol       Date:  2018-09-26       Impact factor: 20.096

Review 3.  Epidemiological evidence on environmental tobacco smoke and cancers other than lung or breast.

Authors:  Peter N Lee; Alison J Thornton; Janette S Hamling
Journal:  Regul Toxicol Pharmacol       Date:  2016-06-16       Impact factor: 3.271

Review 4.  Tar level of cigarettes smoked and risk of smoking-related diseases.

Authors:  Peter N Lee
Journal:  Inhal Toxicol       Date:  2018-02-28       Impact factor: 2.724

Review 5.  The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks.

Authors:  Marcus G Cumberbatch; Matteo Rota; James W F Catto; Carlo La Vecchia
Journal:  Eur Urol       Date:  2015-07-03       Impact factor: 20.096

6.  Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study.

Authors:  Hilary A Tindle; Meredith Stevenson Duncan; Robert A Greevy; Ramachandran S Vasan; Suman Kundu; Pierre P Massion; Matthew S Freiberg
Journal:  J Natl Cancer Inst       Date:  2018-11-01       Impact factor: 13.506

7.  The population impact of familial cancer, a major cause of cancer.

Authors:  Christoph Frank; Mahdi Fallah; Jianguang Ji; Jan Sundquist; Kari Hemminki
Journal:  Int J Cancer       Date:  2013-10-31       Impact factor: 7.396

8.  Trends in cancer incidence in Connecticut, 1935-1991.

Authors:  A P Polednak
Journal:  Cancer       Date:  1994-11-15       Impact factor: 6.860

9.  Stages of the cigarette epidemic on entering its second century.

Authors:  Michael Thun; Richard Peto; Jillian Boreham; Alan D Lopez
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

10.  The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.

Authors:  Katrina F Brown; Harriet Rumgay; Casey Dunlop; Margaret Ryan; Frances Quartly; Alison Cox; Andrew Deas; Lucy Elliss-Brookes; Anna Gavin; Luke Hounsome; Dyfed Huws; Nick Ormiston-Smith; Jon Shelton; Ceri White; D Max Parkin
Journal:  Br J Cancer       Date:  2018-03-23       Impact factor: 7.640

View more
  4 in total

1.  Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Authors:  Kari Hemminki; Asta Försti; Akseli Hemminki; Börje Ljungberg; Otto Hemminki
Journal:  PLoS One       Date:  2022-01-04       Impact factor: 3.240

2.  Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century.

Authors:  Anni I Koskinen; Otto Hemminki; Asta Försti; Kari Hemminki
Journal:  BMC Cancer       Date:  2022-03-02       Impact factor: 4.430

Review 3.  Toxic effects of smokeless tobacco on female reproductive health: A review.

Authors:  C Laldinsangi
Journal:  Curr Res Toxicol       Date:  2022-03-07

4.  Adolescents' Perceptions of Harmfulness of Tobacco and Tobacco-like Products in Finland.

Authors:  Salma El-Amin; Jaana M Kinnunen; Arja Rimpelä
Journal:  Int J Environ Res Public Health       Date:  2022-01-28       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.